Sarasa MA Johnson, Francis Vekeman, Luan Luan, Patrick Hlavacek, Aster Meche, Chai Hyun Kim, Paul Cislo, Didem Aydin, Marco Dibonaventura. "Comparison of elranatamab's progression-free survival, duration of response, and overall survival from MagnetisMM-3 versus real-world external control arms: A subgroup analysis of China-predominant treatment regimens." Blood (2025). https://doi.org/10.1182/blood-2025-8128